ArticleNeurology and therapy2017

Quantifying the Benefits of Dimethyl Fumarate Over β Interferon and Glatiramer Acetate Therapies on Work Productivity Outcomes in MS Patients.

Andrew Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.